Solid Tumors
A Phase 1/2a, Multicenter, Open-Label, First in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of DB-1311 in Subjects With Advanced/Metastatic Solid Tumors (DB-1311-O-1001)
- Details
ClinicalTrials.gov ID:
NCT05914116
Diagnosis Type:
NA
USOR Number:
- Address
,
P: